Mid-Term Outcomes Following Percutaneous Pulmonary Valve Implantation Using the "Folded Melody Valve" Technique
- PMID: 33726503
- PMCID: PMC8055198
- DOI: 10.1161/CIRCINTERVENTIONS.120.009707
Mid-Term Outcomes Following Percutaneous Pulmonary Valve Implantation Using the "Folded Melody Valve" Technique
Abstract
Background: The folded valve is a manual shortening of the Melody device, which has been validated as a valuable therapeutic option for the management of dysfunctional right ventricular outflow tracts needing a short valved stent. In this article, we aimed to evaluate, in a multicenter cohort, the mid-term outcomes of patients in whom a percutaneous pulmonary valve implantation was performed using the folded valve technique.
Methods: A 2012 to 2018 retrospective multicenter study was performed in 7 European institutions. All patients who benefit from percutaneous pulmonary valve implantation with a folded Melody valve were included.
Results: A total of 49 patients (median age, 19 years [range 4–56], 63% male) were included. The primary percutaneous pulmonary valve implantation indication was right ventricular outflow tract stenosis (n=19; 39%), patched native right ventricular outflow tracts were the most common substrate (n=15; 31%). The folded technique was mostly used in short right ventricular outflow tracts (n=28; 57%). Procedural success was 100%. After a median follow-up of 28 months (range, 4–80), folded Melody valve function was comparable to the immediate postimplantation period (mean transvalvular peak velocity=2.6±0.6 versus 2.4±0.6 m/s, P>0.1; only 2 patients had mild pulmonary regurgitation). Incidence rate of valve-related reinterventions was 2.1% per person per year (95% CI, 0.1%–3.9%). The probability of survival without valve-related reinterventions at 36 months was 90% (95% CI, 76%–100%).
Conclusions: The folded Melody valve is a safe technique with favorable mid-term outcomes up to 6.5 years after implantation, comparable with the usual Melody valve implantation procedure. Complications and reinterventions rates were low, making this technique relevant in selected patients.
Keywords: incidence; probability; pulmonary valve; retrospective; stent.
Figures





References
-
- Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D, Acar P, Le Bidois J, Sidi D, Kachaner J. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403–1405. doi: 10.1016/S0140-6736(00)02844-0 - PubMed
-
- Aboulhosn J, Levi DS. Percutaneous pulmonary valve implantation: is earlier valve implantation better? Circ Cardiovasc Interv. 2015;8:e002260. doi: 10.1161/CIRCINTERVENTIONS.115.002260 - PubMed
-
- Jalal Z, Thambo JB, Boudjemline Y. The future of transcatheter pulmonary valvulation. Arch Cardiovasc Dis. 2014;107:635–642. doi: 10.1016/j.acvd.2014.07.046 - PubMed
-
- Plessis J, Hascoët S, Baruteau A, Godart F, Le Gloan L, Warin Fresse K, Tahhan N, Riou JY, Guyomarch B, Petit J, et al. . Edwards SAPIEN transcatheter pulmonary valve implantation: results from a French Registry. JACC Cardiovasc Interv. 2018;11:1909–1916. doi: 10.1016/j.jcin.2018.05.050 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources